Welcome from our CEO
Tina Garvey, Chief Executive, Retina UK
RECORDING: Annual Conference – 19 September 2026
Video recordings: Retina UK Annual Conference 2026
Understanding clinical trials and potential new therapies – what’s in the pipeline?
A panel with representatives from biotechnology companies Sepul Bio, Alkeus and AAVantgarde.
The participant perspective – reflections on taking part in clinical studies
Tina Garvey, Chief Executive, Retina UK. Martin McKibbin, Consultant Ophthalmologist, University of Leeds. James Moore, who is living with inherited sight loss. Bhavna Tailor, Chief Executive, Stargardts Connected and Ethan Tailor, who is living with inherited sight loss.
From innovation to independence: assistive technology for inherited sight loss
Barrie Lane, Tech Advisor at Beacon Centre. Keith Dear, Tech Advisor at Sight for Surrey. Mark Baxter, Information and Support Coordinator, Retina UK. Anna Holloway and Ellie Dowdy, Retina UK Tech Peer Support Group volunteers.
Income to impact: the difference you can make
Jess Mortlock, Interim Director of Income Development. Tam Sanford and Lisa Sanford, who have a child living with inherited sight loss.
Latest developments in stem cell derived therapies
Professor Robin Ali, Director of the Centre for Gene Therapy & Regenerative Medicine, KCL.
Closing remarks
Tina Garvey, Chief Executive, Retina UK.